Bojarska-Junak A - Search Results

1

Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells.

Karp M, Karczmarczyk A, Bojarska-Junak A, Purkot J, Chojnacki M, ZajĄc M, Korpysz M, Tomczak W, Hus M, Morawska M, Giannopoulos K. Karp M, et al. Anticancer Res. 2020 Nov;40(11):6327-6335. doi: 10.21873/anticanres.14653. Anticancer Res. 2020. PMID: 33109570

2

Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.

Dmoszyńska A, Roliński J, Bojarska-Junak A, Mańko J, Jawniak D, Walter-Croneck A, Soroka-Wojtaszko M, Hus M. Dmoszyńska A, et al. Pol J Pharmacol. 2001 Nov-Dec;53(6):709-13. Pol J Pharmacol. 2001. PMID: 11985351 Free article.

3

Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.

Dmoszyńska A, Bojarska-Junak A, Domański D, Roliński J, Hus M, Soroka-Wojtaszko M. Dmoszyńska A, et al. Leuk Lymphoma. 2002 Feb;43(2):401-6. doi: 10.1080/10428190290006224. Leuk Lymphoma. 2002. PMID: 11999576

4

Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A. Bojarska-Junak A, et al. Haematologica. 2002 May;87(5):490-9. Haematologica. 2002. PMID: 12010662

5

Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Roliński J, Kawiak J. Bojarska-Junak A, et al. Folia Histochem Cytobiol. 2005;43(1):19-23. Folia Histochem Cytobiol. 2005. PMID: 15871558

6

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.

Hus I, Roliński J, Tabarkiewicz J, Wojas K, Bojarska-Junak A, Greiner J, Giannopoulos K, Dmoszyńska A, Schmitt M. Hus I, et al. Leukemia. 2005 Sep;19(9):1621-7. doi: 10.1038/sj.leu.2403860. Leukemia. 2005. PMID: 15990861 Clinical Trial.

7

Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.

Giannopoulos K, Li L, Bojarska-Junak A, Rolinski J, Dmoszynska A, Hus I, Greiner J, Renner C, Döhner H, Schmitt M. Giannopoulos K, et al. Int J Oncol. 2006 Jul;29(1):95-103. Int J Oncol. 2006. PMID: 16773189

8

Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL).

Bojarska-Junak A, Giannopoulos K, Kowal M, Dmoszyńska A, Roliński J. Bojarska-Junak A, et al. Cytometry B Clin Cytom. 2006 Jul 15;70(4):293-301. doi: 10.1002/cyto.b.20133. Cytometry B Clin Cytom. 2006. PMID: 16906577 Free article.

9

The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide.

Giannopoulos K, Schmitt M, Własiuk P, Chen J, Bojarska-Junak A, Kowal M, Roliñski J, Dmoszyñska A. Giannopoulos K, et al. Leukemia. 2008 Jan;22(1):222-4. doi: 10.1038/sj.leu.2404869. Epub 2007 Jul 26. Leukemia. 2008. PMID: 17657216 No abstract available.

10

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.

Hus I, Schmitt M, Tabarkiewicz J, Radej S, Wojas K, Bojarska-Junak A, Schmitt A, Giannopoulos K, Dmoszyńska A, Roliński J. Hus I, et al. Leukemia. 2008 May;22(5):1007-17. doi: 10.1038/leu.2008.29. Epub 2008 Mar 6. Leukemia. 2008. PMID: 18323802 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters